表紙
市場調查報告書
商品編碼
1028127

全球羊膜產品市場(~2026):類型(羊膜(冷凍保存的羊膜/脫水羊水)/羊水懸浮液)/用途(傷口治療/眼科/骨科手術)/最終用戶(醫院/ASC)/地區

Amniotic Products Market by Type (Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Amniotic Suspensions), Application (Wound Care, Ophthalmology, Orthopedics), End User (Hospitals, ASCs) - Global Forecast to 2026

出版日期: | 出版商: MarketsandMarkets | 英文 198 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

預測期內,全球羊膜產品市場預計將以 8.2% 的複合年增長率增長,從 2021 年的 7 億美元增長到 2026 年的 10 億美元。

目標患者人群增加、燒傷發病率增加、傷口護理和管理意識計劃、風險資本投資和政府資金增加、創傷性傷口增加、羊膜移植增加、眼科/美容等因素正在推動骨科手術的增加市場的增長。

按類型劃分,羊膜部門預計將在預測期內引領市場。通過應用,預計傷口護理部門在預測期內將擁有最大的份額。由於潰瘍、創傷、手術傷口、燒傷發生率增加以及需要先進的治療技術等因素,預計會出現增長。

本報告探討羊膜產品的全球市場、市場定義和概述、價值鏈、新型冠狀病毒感染(COVID-19)等市場影響因素分析、技術和專利分析、市場規模轉變/預測,類型/用途/最終用戶/地區/主要國家等,按各類分類、競爭環境、主要公司概況等細分。

目錄

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

  • 市場動態
    • 促進因素
    • 市場機會
    • 挑戰
  • 範圍/場景
  • COVID-19 的影響
  • 影響客戶業務的趨勢
  • 價格分析
  • 供應鏈
  • 價值鏈
  • 生態系統
  • 技術分析
  • 專利分析
  • 貿易分析
  • 監管狀態
  • 波特五力分析

第 6 章市場分析/預測:按類型

  • 羊膜
    • 冷凍保存的羊膜
    • 脫水羊膜
  • 羊水懸浮液

第 7 章市場分析/預測:按應用

  • 傷口護理
  • 骨科
  • 眼科
  • 其他

第 8 章市場分析/預測:按最終用戶

  • 醫院/門診手術中心
  • 其他

第 9 章市場分析/預測:按地區/主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章競爭形勢

  • 概述
  • 大公司的戰略
  • 收入份額分析
  • 市場份額分析
  • 企業評估象限
  • 企業評估象限:中小企業/初創企業
  • 競爭場景
  • 企業足跡分析

第 11 章公司簡介

  • 主要公司
    • MIMEDX
    • SMITH & NEPHEW PLC
    • ORGANOGENESIS INC.
    • INTEGRA LIFESCIENCES
    • STRYKER
    • APPLIED BIOLOGICS
    • CELULARITY INC.
    • KATENA PRODUCTS, INC.
    • LUCINA BIOSCIENCES
    • NEXT BIOSCIENCES
    • SKYE BIOLOGICS HOLDINGS, LLC
    • SURGENEX
  • 其他有力企業
    • TISSUETECH, INC.
    • VENTRIS MEDICAL, LLC
    • STIMLABS LLC
    • VIVEX BIOLOGICS
    • LIFECELL INTERNATIONAL PVT. LTD.
    • NUVISION BIOTHERAPIES LTD
    • GENESIS BIOLOGICS
    • SURGILOGIX
    • TIDES MEDICAL
    • ORTHOFIX MEDICAL INC.
    • ALLOSOURCE
    • MERAKRIS THERAPEUTICS
    • MTF BIOLOGICS

第12章 附錄

目錄
Product Code: MD 7637

The global amniotic products market is projected to reach USD 1.0 billion by 2026 from USD 0.7 billion in 2021, at a CAGR of 8.2% during the forecast period. The growth in this market can be attributed to the growth in the target patient population, rising incidence of burn injuries, awareness programs for wound care treatment and management, rising venture capital investments and government funding, increasing number of traumatic wounds, growing number of amniotic membrane transplantations, and the increasing number of ophthalmology, cosmetic, and orthopedic surgeries. The amniotic products market is segmented based on type, application, end user, and region.

"Amniotic membrane segment is expected to dominate the market during the forecast period."

Based on type, the amniotic products market is segmented into amniotic membranes and amniotic suspensions. Amniotic membrane account for the largest share of the amniotic products market. The large share of this segment can be attributed to to its increased use in a number of procedures. Moreover, amniotic membranes are more effective than amniotic suspensions.

"Wound care segment to dominate the market during the forecast period."

Based on application, the amniotic products market is segmented into wound care, ophthalmology, orthopedics, and other applications. The wound care applications segment commanded the largest share of the amniotic products market. The large share of this segment can be attributed to the growing incidence of ulcers, traumatic and surgical wounds, and burns and the need for advanced technologies for treatment.

"Hospitals& Ambulatory Surgery Centers segment to dominate the market during the forecast period."

Based on end user, the amniotic products market is segmented into hospitals & ambulatory surgery centers (ASCs) and other end users (research institutes and laboratories). Hospitals, and ASCs for the largest share of the amniotic products market. The large share is attributed to the rising incidence of hospital-acquired pressure ulcers, the increasing number of severe burn cases and rising awareness about advanced burn care treatment, and the availability of reimbursement.

"North America will dominate the market during the forecast period."

The global amniotic products market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, and the Rest of Asia Pacific), Latin America and Middle East & Africa. In 2020, North America dominated the global amniotic products market, followed by Europe. The large share of the North American market can be attributed to the high prevalence of target diseases, increasing geriatric population, rising awareness about advanced treatment options, and the strong presence of key market players in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type -Tier 1: 48%,Tier 2: 34% and Tier 3: 18%
  • By Designation - C-level:33%, D-level:40%, and Others:27%
  • By Region - North America:36%, Europe:28%, Asia Pacific:19%, Latin America: 10%, and Middle East & Africa: 7%

List of Companies Profiled in the Report

  • MiMedx (US)
  • Smith & Nephew (UK)
  • Organogenesis Inc. (US)
  • Integra LifeSciences (US)
  • Stryker (US)
  • Applied Biologics (US)
  • Celularity, Inc. (US)
  • Katena Products, Inc. (US)
  • Lucina BioSciences (US)
  • Next Biosciences (South Africa)
  • Skye Biologics Holdings, LLC (US)
  • Surgenex (US)
  • TissueTech, Inc. (US)
  • Ventris Medical, LLC (US)
  • StimLabs LLC (US)
  • VIVEX Biologics, Inc. (US)
  • LifeCell International Pvt. Ltd. (India)
  • NuVision Biotherapies Ltd. (UK)
  • Genesis Biologics (US)
  • Surgilogix (US)
  • Tides Medical (US)
  • Orthofix Medical Inc. (US)
  • AlloSource (US)
  • Merakris Therapeutics (US)
  • MTF Biologics (US)

Research Coverage:

This report provides a detailed picture of the global amniotic productsmarket. It aims at estimating the size and future growth potential of the market across different segments, such astype, application, end userand region. The report also analyzes factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total amniotic products market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on amniotic products offered by the top 25 players in the amniotic products market. The report analyses the amniotic products market by product, application, end user and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various amniotic products across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the amniotic products market.

Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the amniotic products market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • FIGURE 1 AMNIOTIC PRODUCTS MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.1 GROWTH FORECAST
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 6 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY
    • 2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
  • 2.6 LIMITATIONS
  • 2.7 RISK ASSESSMENT
  • 2.8 GROWTH RATE ASSUMPTIONS
  • 2.9 COVID-19 ECONOMIC ASSESSMENT
  • 2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

    • FIGURE 10 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 AMNIOTIC PRODUCTS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 AMNIOTIC PRODUCTS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 AMNIOTIC PRODUCTS MARKET OVERVIEW
    • FIGURE 14 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH
  • 4.2 AMNIOTIC PRODUCTS MARKET, BY TYPE (2021-2026)
    • FIGURE 15 AMNIOTIC MEMBRANES SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 4.3 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE AND COUNTRY (2020)
    • FIGURE 16 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN AMNIOTIC PRODUCTS MARKET IN 2020
  • 4.4 AMNIOTIC PRODUCTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 US AND UK TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • FIGURE 18 AMNIOTIC PRODUCTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growth in the target patient population
    • TABLE 1 GLOBAL PREVALENCE OF DIABETES
      • 5.2.1.2 Rising incidence of burn injuries
      • 5.2.1.3 Awareness programs for wound care treatment and management
    • TABLE 2 WOUND CARE AWARENESS INITIATIVES
      • 5.2.1.4 Rising venture capital investments and government funding
    • TABLE 3 FUNDING FOR REGENERATIVE MEDICINE RESEARCH BY THE NIH UNDER THE 21ST CENTURY CURES ACT
    • FIGURE 19 ARTICLES RELATED TO AMNIOTIC PRODUCTS PUBLISHED FROM 2010 TO 2020
      • 5.2.1.5 Increasing number of traumatic wounds
      • 5.2.1.6 Growing number of amniotic membrane transplantations
    • TABLE 4 NO. OF AMNIOTIC MEMBRANE TRANSPLANTATIONS PERFORMED IN UNIVERSITY EYE HOSPITAL TUBINGEN, GERMANY
      • 5.2.1.7 Increasing number of ophthalmology, cosmetic, and orthopedic surgeries
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Emerging economies
    • TABLE 5 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC
      • 5.2.2.2 Implementation of the 21st Century Cures Act (US)
      • 5.2.2.3 Increasing demand for stem cell research and regenerative medicine
    • FIGURE 20 STEM CELL RESEARCH FUNDING IN THE LAST 10 YEARS
    • TABLE 6 NIH FUNDING FOR CELL-BASED RESEARCH, 2016-2021 (USD MILLION)
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Complications and limitations associated with the use of amniotic membranes
  • 5.3 RANGES/SCENARIOS
    • 5.3.1 AMNIOTIC PRODUCTS MARKET
    • FIGURE 21 PESSIMISTIC SCENARIO
    • FIGURE 22 OPTIMISTIC SCENARIO
    • FIGURE 23 REALISTIC SCENARIO
  • 5.4 COVID-19 IMPACT ON THE AMNIOTIC PRODUCTS MARKET
  • 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • 5.5.1 REVENUE SHIFT & REVENUE POCKETS FOR AMNIOTIC PRODUCT MANUFACTURERS
    • 5.5.2 REVENUE SHIFT FOR THE AMNIOTIC PRODUCTS MARKET
  • 5.6 PRICING ANALYSIS
    • TABLE 7 PRICES OF AMNIOTIC PRODUCTS
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 DIRECT DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.8 VALUE CHAIN ANALYSIS
    • FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE DEVELOPMENT PHASE
  • 5.9 ECOSYSTEM ANALYSIS
    • 5.9.1 ROLE IN THE ECOSYSTEM
    • TABLE 8 ROLE OF KEY PLAYERS IN THE ECOSYSTEM
    • FIGURE 26 KEY PLAYERS IN THE AMNIOTIC PRODUCTS ECOSYSTEM
  • 5.10 TECHNOLOGY ANALYSIS
  • 5.11 PATENT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • TABLE 9 IMPORT DATA FOR EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANOTHERAPEUTIC USE, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 10 EXPORT DATA FOR EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANOTHERAPEUTIC USE, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.13 REGULATORY LANDSCAPE
    • 5.13.1 NORTH AMERICA
    • 5.13.2 EUROPE
    • 5.13.3 EMERGING COUNTRIES
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 11 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.14.2 BARGAINING POWER OF SUPPLIERS
    • 5.14.3 BARGAINING POWER OF BUYERS
    • 5.14.4 THREAT OF SUBSTITUTES
    • 5.14.5 THREAT OF NEW ENTRANTS

6 AMNIOTIC PRODUCTS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 PRIMARY NOTES
    • TABLE 12 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 13 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
  • 6.3 AMNIOTIC MEMBRANES
    • TABLE 14 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 15 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 16 AMNIOTIC MEMBRANES MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 17 AMNIOTIC MEMBRANES MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.1 CRYOPRESERVED AMNIOTIC MEMBRANES
      • 6.3.1.1 Cryopreserved amniotic membranes will dominate the amniotic membranes market during the forecast period
    • TABLE 18 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 19 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.2 DEHYDRATED AMNIOTIC MEMBRANES
      • 6.3.2.1 Logistical advantages of dehydrated amniotic membranes over cryopreserved amniotic membranes to drive market growth
    • TABLE 20 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 21 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.4 AMNIOTIC SUSPENSIONS
    • 6.4.1 ANTI-INFLAMMATORY AND ANTIMICROBIAL PROPERTIES OF AMNIOTIC SUSPENSIONS TO DRIVE MARKET GROWTH
    • TABLE 22 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 23 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2020-2026 (USD MILLION)

7 AMNIOTIC PRODUCTS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 PRIMARY NOTES
    • TABLE 24 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 25 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
  • 7.3 WOUND CARE
    • 7.3.1 WOUND CARE IS THE LARGEST APPLICATION SEGMENT OF THE AMNIOTIC PRODUCTS MARKET
    • TABLE 26 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 27 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE, BY REGION, 2020-2026 (USD MILLION)
  • 7.4 ORTHOPEDICS
    • 7.4.1 BENEFITS OFFERED BY AMNIOTIC PRODUCTS FOR ORTHOPEDIC APPLICATIONS TO DRIVE MARKET GROWTH
    • TABLE 28 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDICS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 29 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDICS, BY REGION, 2020-2026 (USD MILLION)
  • 7.5 OPHTHALMOLOGY
    • 7.5.1 LIGHTWEIGHT, THIN, AND ELASTIC NATURE OF AMNIOTIC MEMBRANES MAKES THEM SUITABLE FOR USE IN OPHTHALMOLOGY
    • TABLE 30 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 31 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY, BY REGION, 2020-2026 (USD MILLION)
  • 7.6 OTHER APPLICATIONS
    • TABLE 32 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 33 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2026 (USD MILLION)

8 AMNIOTIC PRODUCTS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 34 AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 35 AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 8.2 HOSPITALS & AMBULATORY SURGERY CENTERS
    • 8.2.1 HOSPITALS & ASCS FORM THE LARGEST END-USER SEGMENT OF THE AMNIOTIC PRODUCTS MARKET
    • TABLE 36 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED IN THE US
    • TABLE 37 AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 38 AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY REGION, 2020-2026 (USD MILLION)
  • 8.3 OTHER END USERS
    • TABLE 39 AMNIOTIC PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 40 AMNIOTIC PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2020-2026 (USD MILLION)

9 AMNIOTIC PRODUCTS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 41 AMNIOTIC PRODUCTS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 42 AMNIOTIC PRODUCTS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET SNAPSHOT
    • TABLE 43 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
    • TABLE 44 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 45 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 46 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 47 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 48 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 49 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 50 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 52 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American amniotic products market
    • TABLE 53 US: KEY MACROINDICATORS
    • TABLE 54 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 55 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 56 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 57 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 58 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 59 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 60 US: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 61 US: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Rising prevalence of target diseases to drive market growth
    • TABLE 62 CANADA: KEY MACROINDICATORS
    • TABLE 63 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 64 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 65 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 66 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 67 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 68 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 69 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 70 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 71 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
    • TABLE 72 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 73 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 74 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 75 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 76 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 77 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 78 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 79 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 80 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.3.1 UK
      • 9.3.1.1 The UK accounted for the largest share of the European amniotic products market in 2020
    • TABLE 81 UK: KEY MACROINDICATORS
    • TABLE 82 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 83 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 84 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 85 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 86 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 87 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 88 UK: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 89 UK: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Increasing incidence of diabetes to drive market growth in Germany
    • TABLE 90 GERMANY: KEY MACROINDICATORS
    • TABLE 91 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 92 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 93 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 94 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 95 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 96 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 97 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 98 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Rising government support to drive the demand for amniotic products in France
    • TABLE 99 FRANCE: KEY MACROINDICATORS
    • TABLE 100 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 101 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 102 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 103 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 104 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 105 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 106 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 107 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.3.4 REST OF EUROPE
    • TABLE 108 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
    • TABLE 109 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 110 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 111 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 112 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 113 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 114 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 115 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 116 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 28 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET SNAPSHOT
    • TABLE 117 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 123 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 124 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 126 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China to dominate the Asia Pacific amniotic products market during the forecast period
    • TABLE 127 CHINA: KEY MACROINDICATORS
    • TABLE 128 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 129 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 130 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 131 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 132 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 133 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 134 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 135 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Growing geriatric population to drive market growth in Japan
    • TABLE 136 JAPAN: KEY MACROINDICATORS
    • TABLE 137 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 138 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 139 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 140 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 141 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 142 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 143 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 144 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.4.3 REST OF ASIA PACIFIC
    • TABLE 145 ROAPAC: DIABETES PREVALENCE (% OF POPULATION AGED 20-79), BY COUNTRY, 2019
    • TABLE 146 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 147 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 148 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 149 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 150 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 151 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 152 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 153 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH
    • TABLE 154 LATIN AMERICA: DIABETES PREVALENCE (% OF POPULATION AGED 20-79), BY COUNTRY, 2019
    • TABLE 155 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 156 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 157 LATIN AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 158 LATIN AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 159 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 160 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 161 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 162 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 SIGNIFICANT GROWTH IN HEALTHCARE INFRASTRUCTURE AND GOVERNMENT INITIATIVES TO FAVOR MARKET GROWTH
    • TABLE 163 MIDDLE EAST & AFRICA: DIABETES PREVALENCE (% OF POPULATION AGED 20-79), BY COUNTRY, 2019
    • TABLE 164 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 165 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 166 MIDDLE EAST & AFRICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 167 MIDDLE EAST & AFRICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 168 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 169 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 170 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 171 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 172 OVERVIEW OF STRATEGIES ADOPTED BY KEY AMNIOTIC PRODUCT MARKET PLAYERS
  • 10.3 REVENUE SHARE ANALYSIS
    • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE AMNIOTIC PRODUCTS MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 30 AMNIOTIC PRODUCTS MARKET SHARE ANALYSIS, 2020
    • TABLE 173 AMNIOTIC PRODUCTS MARKET: DEGREE OF COMPETITION (2020)
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 31 AMNIOTIC PRODUCTS MARKET: COMPANY EVALUATION QUADRANT (2020)
  • 10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 32 AMNIOTIC PRODUCTS MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020)
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 DEALS
    • TABLE 174 DEALS
    • 10.7.2 PRODUCT LAUNCHES & APPROVALS
    • TABLE 175 PRODUCT LAUNCHES & APPROVALS
    • 10.7.3 OTHER DEVELOPMENTS
    • TABLE 176 OTHER DEVELOPMENTS
  • 10.8 COMPANY FOOTPRINT ANALYSIS
    • TABLE 177 COMPANY FOOTPRINT ANALYSIS
    • TABLE 178 COMPANY PRODUCT FOOTPRINT
    • TABLE 179 COMPANY REGIONAL FOOTPRINT

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View)**
    • 11.1.1 MIMEDX
    • TABLE 180 MIMEDX: BUSINESS OVERVIEW
    • FIGURE 33 MIMEDX: COMPANY SNAPSHOT (2020)
    • 11.1.2 SMITH & NEPHEW PLC
    • TABLE 181 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
    • FIGURE 34 SMITH & NEPHEW: COMPANY SNAPSHOT (2020)
    • 11.1.3 ORGANOGENESIS INC.
    • TABLE 182 ORGANOGENESIS INC.: BUSINESS OVERVIEW
    • FIGURE 35 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020)
    • 11.1.4 INTEGRA LIFESCIENCES
    • TABLE 183 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW
    • FIGURE 36 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020)
    • 11.1.5 STRYKER
    • TABLE 184 STRYKER: BUSINESS OVERVIEW
    • FIGURE 37 STRYKER: COMPANY SNAPSHOT (2020)
    • 11.1.6 APPLIED BIOLOGICS
    • TABLE 185 APPLIED BIOLOGICS: BUSINESS OVERVIEW
    • 11.1.7 CELULARITY INC.
    • TABLE 186 CELULARITY INC.: BUSINESS OVERVIEW
    • 11.1.8 KATENA PRODUCTS, INC.
    • TABLE 187 KATENA PRODUCTS, INC.: BUSINESS OVERVIEW
    • 11.1.9 LUCINA BIOSCIENCES
    • TABLE 188 LUCINA BIOSCIENCES: BUSINESS OVERVIEW
    • 11.1.10 NEXT BIOSCIENCES
    • TABLE 189 NEXT BIOSCIENCES: BUSINESS OVERVIEW
    • 11.1.11 SKYE BIOLOGICS HOLDINGS, LLC
    • TABLE 190 SKYE BIOLOGICS HOLDINGS, LLC: BUSINESS OVERVIEW
    • 11.1.12 SURGENEX
    • TABLE 191 SURGENEX: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 TISSUETECH, INC.
    • 11.2.2 VENTRIS MEDICAL, LLC
    • 11.2.3 STIMLABS LLC
    • 11.2.4 VIVEX BIOLOGICS
    • 11.2.5 LIFECELL INTERNATIONAL PVT. LTD.
    • 11.2.6 NUVISION BIOTHERAPIES LTD
    • 11.2.7 GENESIS BIOLOGICS
    • 11.2.8 SURGILOGIX
    • 11.2.9 TIDES MEDICAL
    • 11.2.10 ORTHOFIX MEDICAL INC.
    • 11.2.11 ALLOSOURCE
    • 11.2.12 MERAKRIS THERAPEUTICS
    • 11.2.13 MTF BIOLOGICS
  • * Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS